|
Catching
The Chinese Dragon
China and India have emerged as important for the multinationals'
global market strategy. With vast populations, and scientific
and technical resources, both countries have a lot to offer
the pharmaceutical industry. How do the two compare? Sapna
Dogra finds out.
Towards
a new paradigm
From innovation in field force strategy to the need for markets
free of price control, Ranjit Shahani, Vice-President and
MD of Novartis and President of the OPPI,talks about a host
of issues and prospects for the pharma industry to Deepali
Gupta.
Glenmark
acquires sales and marketing company in SA
Glenmark Pharmaceuticals SA (GPSA) has acquired Bouwer Bartlett
Pty (Bouwer Bartlett), a South African sales and marketing
company for an undisclosed amount. The acquisition provides
Glenmark a strategic entry point into the South African market.
Serum
Institute launches Td-Vac for adults
Serum Institute of India, announced the launch of Td-Vac,
a Tetanus and Diphtheria vaccine for combating the fatal diseases
in adolescents and adults.
JB
Chemicals to set up Russian subsidiary
JB Chemicals and Pharmaceuticals Ltd (JBCPL) a leading pharmaceutical
player with a dominant presence in Russia and CIS countries
announced its plans to set up a wholly owned subsidiary in
Moscow, Russia, called ‘OOO Unique Pharmaceuticals Laboratories’.
Orchid
receives USFDA nod for Cefprozil tablets
The Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals
announced that it has received the formal approval from the
USFDA for its ANDA for Cefprozil tablets USP, 250 mg and 500
mg.
Merck,
ICMR collaborate on HPV vaccine trials
MSD India and Indian Council of Medical Research (ICMR) have
collaborated to study Merck's investigational cervical cancer
vaccine, Gardasil designed to protect against quadrivalent
human papillomavirus (HPV) types 6, 11, 16, 18, recombinant
vaccine in the Indian population.
Mankind
Pharma goes on an expansion spree
Going with the acquisition trend in the pharma industry, Mankind
Pharma plans to invest Rs 70 crore in the next two years to
support its expansion plans and achieve an ambitious turnover
of Rs 1,000 crore in the next five years.
Nicholas
Piramal strikes R&D deal with Pfizer
Nicholas Piramal announced the signing of a long-term contract
manufacturing related R&D Services Agreement with Pfizer
International LLC.
Another
feather in the cap for SK Group
Sevantilal and Kantilal Group (SK Group) inaugurated its new
central warehousing depot for Bristol Myers Squibb (BMS) India.
SK Group has been appointed by BMS India as their distributors
for the company's pharma products in India. The recent move
came with an inauguration of the central warehousing depot
at SK Group's Bhiwandi premises.
ReaMetrix
releases Accuford reagent kit
ReaMetrix and Millipore India released the Accuford Tri-TStat
reagent kit. Through an exclusive distribution partnership
in the Indian market, ReaMetrix and Millipore India will bring
a new generation of affordable diagnostics to the public.
Stock
Watch
|
